ATP 4-02.10 governs Army hospitalization (Role 3), including hospitalization organizations, employment, patient movement, logistics, and specialized augmentation.
View ATP 4-02.10 on armypubs.army.mil
It covers Role 3 medical care, hospital center configurations, specialized surgical and medical augmentation organizations, and hospitalization in operational environments. It also addresses medical ethics, patient movement, Class VIII supply, nutrition care, waste, safety, information systems, and telemedicine.
Applies to: The provisions of this appendix are applicable to the Role 3 hospital operations where there is potential of environmental or occupational exposure to hazardous chemicals and waste, hazardous drugs, ionizing and nonionizing radiation, and material contaminated with potentially infectious blood or body fluids.
The HHD, hospital center and field hospital (32-bed) should be deployed and employed together as the smallest element to provide Role 3 hospitalization. (paragraph 3-2)
Further, the field hospital (32-bed) is not designed to be split between two locations. (paragraph 3-2)
The HHD, hospital center provides C2 for up to two functioning field hospitals (32-bed) as well as additional medical augmentation detachments with a combined maximum of 240 beds. (paragraph 3-3)
When further attached to a Role 2 medical company, the FRSD may provide forward resuscitative and surgical interventions to render nontransportable patients sufficiently stable enough to allow for MEDEVAC to a Role 3 hospital. (paragraph 2)
Patients remain at the FRSD (for up to six hours) until they recover from anesthesia; once stabilized they are evacuated as soon as possible. (paragraph 2)